UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the Quarterly Period Ended June 30, 2017

 

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission file number 001-35955

 

VUZIX CORPORATION

(Exact name of registrant as specified in its charter)

 

Delaware   04-3392453
State or other jurisdiction of
incorporation or organization
  (I.R.S. Employer
Identification No.)

 

25 Hendrix Road, Suite A
West Henrietta, New York
  14583
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (585) 359-5900

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to filing requirements for the past 90 days.    Yes  x    No   ¨

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes   x     No   ¨

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ¨ Accelerated filer x

Non-accelerated filer ¨

(Do not check if a smaller reporting company)

Smaller reporting company ¨

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

Indicate by check mark whether the registrant is a shell company (as defined in rule 12b-2 of the Exchange Act). Yes ¨ No x

 

As of August 9, 2017, there were 20,674,742 shares of the registrant’s common stock outstanding.

 

 

 

 

 

Vuzix Corporation

INDEX

 

    Page 
No.
     
Part I – Financial Information 3
     
Item 1. Condensed Consolidated Financial Statements (Unaudited): 3
     
  Consolidated Balance Sheets as of June 30, 2017 and December 31, 2016 3
     
  Consolidated Statement of Changes in Stockholders’ Equity for the Six Months Ended June 30, 2017 4
     
  Consolidated Statements of Operations for the Three and Six Months Ended June 30, 2017 and 2016 5
     
  Consolidated Statement of Cash Flows for the Six Months Ended June 30, 2017 and 2016 6
     
  Notes to the Unaudited Condensed Consolidated Financial Statements 7
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 17
     
Item 3. Quantitative and Qualitative Disclosures About Market Risk 28
     
Item 4. Controls and Procedures 29
     
Part II – Other Information 30
     
Item 1. Legal Proceedings 30
     
Item 1A. Risk Factors 30
     
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 30
     
Item 3. Defaults Upon Senior Securities 30
     
Item 4. Mine Safety Disclosure 30
     
Item 5. Other Information 30
     
Item 6. Exhibits 31
     
Signatures   32

 

2 

 

 

Part 1: FINANCIAL INFORMATION

 

Item 1: Condensed Consolidated Financial Statements

 

VUZIX CORPORATION

 

CONSOLIDATED BALANCE SHEETS

  

  

(Unaudited)

June 30,

   December 31, 
   2017   2016 
ASSETS          
Current Assets          
Cash and Cash Equivalents  $6,129,342   $14,533,944 
Accounts Receivable   142,530    103,314 
Accrued Revenue   420,314     
Inventories, Net   3,407,141    2,651,218 
Manufacturing Vendor Prepayments   206,148    144,168 
Prepaid Expenses and Other Assets   517,512    797,409 
           
Total Current Assets   10,822,987    18,230,053 
           
Long-Term Assets          
Fixed Assets, Net   3,586,193    3,364,908 
Patents and Trademarks, Net   587,127    535,461 
Software Development Costs, Net   171,611    214,838 
           
Total Assets  $15,167,918   $22,345,260 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY          
Current Liabilities          
Accounts Payable  $1,809,146   $1,085,472 
Current Portion of Long-Term Debt, net of discount       1,416,480 
Customer Deposits   47,409    66,162 
Unearned Revenue   139,038    509,572 
Accrued Expenses   1,064,451    1,331,983 
Income and Other Taxes Payable   2,594    12,290 
           
Total Current Liabilities   3,062,638    4,421,959 
           
Long-Term Liabilities          
Derivative Liability   163,987    173,131 
Accrued Expenses   23,333    28,333 
Total Long-Term Liabilities   187,320    201,464 
           
Total Liabilities   3,249,958    4,623,423 
           
Stockholders’ Equity          
Preferred Stock — $.001 Par Value, 5,000,000 Shares Authorized; 49,626 Shares Issued and Outstanding June 30, 2017, and  December 31, 2016   50    50 
Common Stock — $.001 Par Value, 100,000,000 Shares Authorized; 20,609,182 Shares Issued and Outstanding June 30, 2017 and 19,569,247 on December 31, 2016   20,609    19,569 
Additional Paid-in Capital   96,988,013    94,541,168 
Accumulated Deficit   (85,090,712)   (76,838,950)
           
Total Stockholders’ Equity   11,917,960    17,721,837 
           
Total Liabilities and Stockholders’ Equity  $15,167,918   $22,345,260 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

3 

 

  

VUZIX CORPORATION

 

CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY

(Unaudited)

 

   Preferred Stock   Common Stock  

Additional

Paid-In

   Accumulated    
   Shares   Amount   Shares   Amount   Capital   Deficit   Total 
                             
Balance — December 31, 2016   49,626   $50    19,569,247   $19,569   $94,541,168   $(76,838,950)  $17,721,837 
                                    
Conversion of Note Payable & Accrued Interest             827,237    827    1,860,456         1,861,283 
Exercise of Warrants             168,203    168    (168)         
Stock Based Compensation Expense           4,170    4    486,598         486,602 
Exercise of Stock Options             23,782    24    (24)         
Common Stock Issued for Services             16,543    17    99,983         100,000 
Net Loss for the Six Months Ended June 30, 2017                            (8,251,762)   (8,251,762)
                                    
Balance — June 30, 2017   49,626   $50    20,609,182   $20,609   $96,988,013   $(85,090,712)  $11,917,960 

  

The accompanying notes are an integral part of these condensed consolidated financial statements.

  

4 

 

 

VUZIX CORPORATION

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

   For Three Months   For Six Months 
   Ended June 30,   Ended June 30, 
   2017   2016   2017   2016 
                 
Sales of Products  $904,947   $421,377   $1,864,330   $785,217 
Sales of Engineering Services   420,314    139,500    671,594    139,500 
                     
Total Sales   1,325,261    560,877    2,535,924    924,717 
                     
Cost of Sales — Products   1,397,831    647,871    2,351,734    1,250,848 
Cost of Sales — Engineering Services   356,917    39,060    464,917    39,060 
                     
Total Cost of Sales   1,754,748    686,931    2,816,651    1,289,908 
Gross Loss (exclusive of depreciation shown separately below)   (429,487)   (126,054)   (280,727)   (365,191)
Operating Expenses:                    
Research and Development   1,198,940    1,669,043    2,867,748    2,943,756 
Selling and Marketing   800,329    651,547    1,831,328    1,778,046 
General and Administrative   1,308,234    1,199,427    2,543,417    2,085,744 
Depreciation and Amortization   242,979    183,686    482,809    352,874 
                     
Loss from Operations   (3,979,969)   (3,829,757)   (8,006,029)   (7,525,611)
                     
Other Income (Expense)                    
Investment Income   14,944    3,324    32,844    12,779 
Other Taxes   (11,600)   (13,904)   (22,150)   (34,625)
Foreign Exchange Loss   (26,151)   (3,536)   (25,053)   (7,484)
 (Loss) Gain on Derivative Valuation   (13,416)   (99,679)   9,144    1,987 
Amortization of Senior Term Debt Discount   (21,568)   (114,816)   (155,760)   (236,022)
Amortization of Deferred Financing Costs   (8,048)   (11,580)   (19,500)   (23,160)
Interest Expense   (24,291)   (33,542)   (65,258)   (67,093)
                     
Total Other Expense   (90,130)   (273,733)   (245,733)   (353,618)
                     
Loss Before Income Taxes   (4,070,099)   (4,103,490)   (8,251,762)   (7,879,229)
Provision (Benefit) for Income Taxes                
                     
Net Loss   (4,070,099)   (4,103,490)   (8,251,762)   (7,879,229)
Preferred Stock Dividends   (424,243)   (399,715)   (837,708)   (793,540)
                     
Loss Attributable to Common Stockholders  $(4,494,342)  $(4,503,205)  $(9,089,470)  $(8,672,769)
                     
Loss per Share                    
Basic and Diluted Loss per Share (Note 2)  $(0.22)  $(0.28)  $(0.45)  $(0.54)
Weighted-average Shares Outstanding Basic and Diluted   20,446,824    16,137,419    20,082,633    16,135,881 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

5 

 

 

VUZIX CORPORATION

 

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

   For the Six Months Ended 
   June 30, 
   2017   2016 
         
Cash Flows from Operating Activities          
Net Loss  $(8,251,762)  $(7,879,229)
Non-Cash Adjustments          
Depreciation and Amortization   482,809    352,874 
Amortization of Software Development Costs in cost of sales products   143,225    143,225 
Stock Based Option Compensation Expense   486,602    349,206 
Amortization of Term Debt Discount   155,760    236,022 
Amortization of Debt Issuance Costs   19,500    23,160 
Common Stock Issued for Services   100,000    175,674 
Loss on Derivative Valuation   (9,144)   (1,987)
(Increase) Decrease in Operating Assets          
Accounts Receivable   (39,216)   223,811 
Accrued Revenue   (420,314)    
Inventories   (755,923)   (121,856)
Vendor Prepayments   (61,980)   (55,163)
Prepaid Expenses and Other Assets   279,898    (210,899)
Increase (Decrease) in Operating Liabilities          
Accounts Payable   723,632    149,734 
Accrued Expense   56,711    179,151 
Customer Deposits   (18,753)   7,123 
Unearned Revenue   (370,534)   191,654 
Income and Other Taxes Payable   (9,695)   11,327 
Accrued Compensation   (124,918)    
Accrued Interest   65,260    (160,967)
           
Net Cash Flows Used in Operating Activities   (7,548,842)   (6,387,140)
           
Cash Flows from Investing Activities          
Purchases of Fixed Assets   (662,993)   (836,541)
Investments in Patents and Trademarks   (92,767)   (56,834)
Investments in Software Development   (100,000)    
           
Net Cash Used in Investing Activities   (855,760)   (893,375)
           
Cash Flows from Financing Activities          
Proceeds from Exercise of Warrants       45,000 
Repayment of Long-Term Debt and Notes Payable       (55,210)
Net Cash Flows Used in Financing Activities       (10,210)
           
Net Decrease in Cash and Cash Equivalents   (8,404,602)   (7,290,725)
Cash and Cash Equivalents — Beginning of Period   14,533,944    11,877,058 
           
Cash and Cash Equivalents — End of Period  $6,129,342   $4,586,333 
Supplemental Disclosures          
Interest Paid in Cash  $39   $11,444 
Conversion of Debt and Accrued Interest  $1,861,283   $22,500 

 

 The accompanying notes are an integral part of these condensed consolidated financial statements.

 

6 

 

 

VUZIX CORPORATION AND SUBSIDIARIES

 

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

  

Note 1 — Basis of Presentation

 

The accompanying unaudited Condensed Consolidated Financial Statements of Vuzix Corporation and Subsidiaries (“the Company") have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Regulation S-X of the Securities and Exchange Commission. Accordingly, the unaudited Condensed Consolidated Financial Statements do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. The condensed consolidated balance sheet as of December 31, 2016 was derived from the audited Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K (the “Annual Report”).

 

The accompanying Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements of the Company as of December 31, 2016, as reported in the Company’s Annual Report.

 

The results of the Company’s operations for any interim period are not necessarily indicative of the results of the Company’s operations for any other interim period or for a full fiscal year.

 

For the six months ended June 30, 2017, Toshiba Japan represented 26% of revenues as compared to 0% in the same 2016 period. As of June 30, 2017 and 2016, Toshiba Japan accounted for 75% and 0% of accounts receivables and accrued revenue, respectively.

 

The accompanying Condensed Consolidated Financial Statements have been prepared assuming that we will continue as a going concern. This basis of accounting contemplates the recovery of our assets and the satisfaction of liabilities in the normal course of business. These Condensed Consolidated Financial Statements do not include any adjustments to the specific amounts and classifications of assets and liabilities, which might be necessary should we be unable to continue as a going concern. The Company incurred a net loss for the first six months of 2017 of $8,251,762. The Company has incurred a net loss consistently over recent years. The Company incurred annual net losses of $19,250,082 in 2016 and $13,427,478 in 2015, and has an accumulated deficit of $85,090,712 as of June 30, 2017.

 

The Company’s cash requirements are primarily for funding operating losses, research, capital expenditures and working capital. Historically, the Company has met these cash needs by borrowings under notes, sales of convertible debt, and the sales of equity. In 2016, we received total net proceeds from public equity offerings of $19,238,015, after underwriting discounts and commissions and other offering expenses.

 

Our cash requirements related to funding operating losses depend on numerous factors, including new product development activities, our ability to commercialize our products, our products’ timely market acceptance, selling prices and gross margins, and other factors. In order for us to achieve positive cash flow from operations, our product sales will need to significantly increase.

  

The Company’s management intends to take actions necessary to continue as a going concern, as discussed herein. The Company will need to grow its business significantly to become profitable and self-sustaining on a cash flow basis. Management’s plans concerning these matters and managing our liquidity includes among other things:

 

  · the commencement of full volume manufacturing of the new M300 Smart Glasses in the spring of 2017, along with expected margin improvements from higher production volumes and assembly offshore, which we successfully completed in June 2017;

 

7 

 

 

  · the recent award of a Smart Glasses development program with Toshiba, which we expect to be completed by early fall 2017 and represents approximately a further $715,000 in revenues during the next two fiscal quarters;

 

  · tighter control of operating costs and reduce spending growth rates wherever possible;

 

  · delay new product tooling and curtail discretionary and non-essential capital expenditures not related to select near-term new products;

 

  · reduce the rate of research and development spending on new technologies, particularly the use of costly external contractors for upcoming Blade 3000 smart glasses that will first be manufactured at our Rochester plant rather than at more costly external contractors; and

 

  · delaying planned new products based on new technology including the M3000 and AR 3000 Smart Glasses.

  

However, if these actions are not successful in the near term, we will have to raise additional capital to maintain operations and/or materially reduce our operating and new product development costs.

 

If the Company raises additional funds, the ownership interest of existing stockholders may be diluted. The amount of such dilution could increase due to the issuance of new warrants or securities with other dilutive characteristics, such as full ratchet anti-dilution clauses or price resets.

 

Based upon our current amount of cash on hand, management’s historical ability to raise capital, and our ability to manage our cost structure and adjust operating plans if and as required, we have concluded that substantial doubt of our ability to continue as a going concern has been alleviated.

 

Note 2 – Loss Per Share

 

Basic loss per share is computed by dividing the loss attributable to common stockholders by the weighted average number of common shares outstanding for the period. Diluted earnings per share reflects the potential dilution from the assumed exercise of stock options and warrants, and the conversion of any convertible debt and convertible preferred shares. During periods of net loss, all common stock equivalents are excluded from the diluted EPS calculation because they are antidilutive. Since the Company reported a net loss for the three and six months ended June 30, 2017 and 2016, the calculation for basic and diluted earnings per share is considered to be the same, as the impact of potential common shares is anti-dilutive. As of June 30, 2017 and December 31, 2016, there were 6,499,941 and 7,227,738 common stock share equivalents, respectively potentially issuable under convertible debt agreements, conversion of preferred shares, options, and warrants that could potentially dilute basic earnings per share in the future.

 

8 

 

 

Note 3 — Inventories, Net

  

Inventories are stated at the lower of cost and net realizable value and consisted of the following:

 

   June 30, 2017   December 31, 2016 
     
Purchased Parts and Components  $2,226,656   $1,990,026 
Work in Process   302,387    454,120 
Finished Goods   1,584,343    831,069 
Less: Reserve for Obsolescence   (706,245)   (623,997)
Net  $3,407,141   $2,651,218 

 

Note 4 — Accrued Expenses

 

Accrued expenses consisted of the following:

 

   June 30, 2017   December 31, 2016 
     
Accrued Wages and Related Costs  $128,063   $119,472 
Accrued Compensation   523,802    648,720 
Accrued Professional Services   155,746    137,099 
Accrued Warranty Obligations   75,603    41,132 
Accrued Interest   171,237    375,560 
Other Accrued Expenses   10,000    10,000 
           
Total  $1,064,451   $1,331,983 

 

Included in the above accrued compensation are amounts owed to officers of the Company for services rendered that remain outstanding primarily for 2016 and prior years. The amounts are not subject to a fixed repayment schedule and they bear interest at a rate of 8% per year, compounding monthly. The related interest amounts included in Accrued Interest were $171,237 and $141,645 respectively at June 30, 2017 and December 31, 2016.

 

The Company has warranty obligations in connection with the sale of certain of its products. The warranty period for its products is generally one year except in certain European countries where it is two years for some products. The costs incurred to provide for these warranty obligations are estimated and recorded as an accrued liability at the time of sale. The Company estimates its future warranty costs based on product-based historical performance rates and related costs to repair. The changes in the Company’s accrued warranty obligations for the six months ended June 30, 2017 and December 31, 2016 were as follows:

   

Accrued Warranty Obligations at December 31, 2016  $41,132 
Reductions for Settling Warranties   (57,718)
Warranties Issued During Period   92,189 
      
Accrued Warranty Obligations at June 30, 2017  $75,603 

 

Note 5 – Derivative Liability and Fair Value Measurements

 

The Company recognized a derivative liability for the warrants to purchase shares of its common stock issued in connection with the equity offering and related debt conversions on August 5, 2013. These warrants have a cashless exercise provision and an exercise price that is subject to adjustment in the event of subsequent equity sales at a lower purchase price (subject to certain exceptions) along with full-ratchet anti-dilution provisions. In accordance with FASB ASC 815-10-25, we measured the derivative liability using a Monte Carlo Options Lattice pricing model at their issuance date and subsequently remeasured the liability on each reporting date.

 

9 

 

 

Accordingly, at the end of each quarterly reporting date, the derivative fair market value is remeasured and adjusted to current market value. As of June 30, 2017 and December 31, 2016 a total of 38,100 warrants were outstanding that contained a full-ratchet anti-dilution provision. In connection with the closing of our sale of shares of Series A Preferred Stock on January 2, 2015 (the “Series A Private Placement”), holders of approximately 86% of outstanding warrants issued by the Company in its public offering and in connection with the conversion by certain holders of the Company’s outstanding debt in connection with the Company’s public offering (collectively, the “Public Offering Warrants”) agreed to irrevocably waive their rights to anti-dilution protection under Section 2(b) of the Public Offering Warrants in the event the Company issues additional securities at a per share price lower than the exercise price of the Public Offering Warrants (the “Public Offering Warrant Waiver”). As a result the related derivative liability was reversed to Nil and reclassified into Stockholders Equity under Additional Paid-In Capital.

 

The Company recognized a derivative liability during the year ended December 31, 2014 for the $3,000,000 of senior convertible notes with a conversion price that is subject to adjustment in the event of subsequent equity sales at a lower purchase price (subject to certain exceptions). In accordance with FASB ASC 815-10-25, we measured the derivative liability of this embedded conversion option using a Monte Carlo Options Lattice pricing model at the June 3, 2014 issuance date as $1,938,988. The value of the derivative liability at issuance was recorded as a discount against the notes in the Long-Term Liabilities section of the balance sheet. Accordingly, at the end of each quarterly reporting date the derivative fair market value is remeasured and adjusted to current market value.

  

The Company has adopted FASB ASC Topic 820 for financial instruments measured at fair value on a recurring basis. FASB ASC Topic 820 defines fair value, establishes a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements.

 

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. FASB ASC Topic 820 establishes a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include:

 

-        Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;

 

-        Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

 

-        Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

 

10 

 

 

The carrying amount of cash, accounts receivable, accounts payable, and accrued expenses approximates their fair value due to their short maturity. The carrying amount of notes payable approximates fair value because stated or implied interest rates approximate current interest rates that are available for debt with similar terms.

 

We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at June 30, 2017:

 

   Total   Level 1   Level 2   Level 3 
                 
Derivative Liability  $163,987   $   $   $163,987 
Total liabilities measured at fair value (Long-Term)  $163,987   $   $   $163,987 

 

We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at December 31, 2016:

 

   Total   Level 1   Level 2   Level 3 
                 
Derivative Liability  $173,131   $   $   $173,131 
Total liabilities measured at fair value (Long-Term)  $173,131   $   $   $173,131 

 

Fair value – December 31, 2016  $173,131 
      
Change in fair value for the period of warrant derivative liability   (9,144)
      
Fair value – June 30, 2017  $163,987 

 

The Monte Carlo Options Lattice pricing model was used to estimate the fair value of the warrants outstanding:

 

   June 30,
2017
   December 31,
2016
 
         
Assumptions for Pricing Model:          
Expected term in years   1.10    1.22 
Volatility range for years   133%   100%
Risk-free interest rate   1.24%   1.47%
Expected annual dividends   None    None 
           
Value of warrants outstanding:          
Fair value of warrants  $163,987   $173,131 

 

Note 6 — Long-Term Debt

 

Long-term debt consisted of the following:

 

    June 30,
2017
   December 31,
2016
 
         
Convertible, Senior Secured Notes payable. The principal is due June 3, 2017 and no payments are required prior to maturity. The notes carry a 5% annual interest rate, payable upon the notes’ maturity. Both the principal plus accrued interest is convertible into shares of the Company’s common stock at $2.25, subject to normal adjustments. The notes are secured by a first security position in all the assets of the Company.       1,591,740 
Convertible, Senior Secured Notes Debt Issuance Costs of $139,340, net of accumulated amortization.       (19,500)
Unamortized debt discount related to derivative liability associated with above notes’ conversion price that is subject to adjustment in the event of subsequent equity sales at a lower purchase price (subject to certain exceptions). Upon issuance on June 3, 2014 the discount was $1,938,988.       (155,760)
           
   $   $1,416,480 
Less: Amount Due Within One Year       (1,416,480)
           
Amount Due After One Year  $   $ 

 

11 

 

 

 

All of the $1,591,740 in Convertible Senior Secured Notes outstanding as of December 31, 2016, were converted into 707,440 shares of common stock during the six months ended June 30, 2017 and $269,543 of accrued interest on these Notes were converted into 119,797 shares of common stock during the six months ended June 30, 2017.

 

Note 7 — Income Taxes

  

The Company’s effective income tax rate is a combination of federal, state and foreign tax rates and differs from the U.S. statutory rate due to taxes on foreign income, permanent differences including tax-exempt interest, and the resolution of tax uncertainties, offset by a valuation allowance against U.S. deferred income tax assets.

  

Note 8 — Capital Stock

 

Preferred stock

 

The Company may issue shares of undesignated preferred stock in one or more series. The Board of Directors is authorized to establish and designate the different series and to fix and determine their voting powers and other special rights and qualifications. A total of 5,000,000 shares of preferred stock are authorized as of June 30, 2017 and December 31, 2016, 49,626 of which are designated as Series A Preferred Stock. There were 49,626 shares of Series A Preferred Stock issued and outstanding on June 30, 2017 and December 31, 2016.

 

On January 2, 2015 the Company closed a sale of Series A Preferred Stock to Intel Corporation (the “Series A Purchaser”), pursuant to which we issued and sold an aggregate of 49,626 shares of the Company’s Series A Preferred Stock, at a purchase price of $500 per share, for an aggregate purchase price of $24,813,000. Each share of Series A Preferred Stock is convertible, at the option of the Series A holder, into 100 shares of the Company’s common stock (determined by dividing the Series A Original Issue Price of $500 by the Series A Conversion Price). The Series A Conversion Price is $5.00, subject to adjustment in the event of stock splits, dividends or other combinations.

 

Each share of Series A Preferred Stock is entitled to receive dividends at a rate of 6% per year, compounded quarterly and payable in cash or in kind, at the Company’s sole discretion. As of June 30, 2017, total accrued and unpaid preferred dividends were $3,971,837. As of December 31, 2016, total accrued and unpaid preferred dividends were $3,134,129. There were no declared preferred dividends owed as of June 30, 2017 or December 31, 2016.

 

12 

 

 

The Series A Purchaser has the right, but not the obligation, to participate in any proposed issuance by the Company of its securities, subject to certain exceptions and in such amount as is sufficient to maintain the Series A Purchaser’s ownership percentage in the Company, calculated immediately prior to such applicable financing, at a purchase price equal to the per share price of the Company’s securities in such applicable financing.

 

In connection with the Series A Private Placement, the Company entered into an investor’s rights agreement with the Series A Purchaser, pursuant to which the Company agreed to file a “resale” registration statement with the Securities and Exchange Commission (the “SEC”) covering all the resale of shares of common stock issuable upon conversion of the Series A Preferred Stock. The Company’s registration statement covering the resale of these shares was declared effective by the SEC on February 17, 2015.

 

Common Stock

 

The Company’s authorized common stock consists of 100,000,000 shares, par value of $0.001 as of June 30, 2017 and December 31, 2016. There were 20,609,182 and 19,569,247 shares of common stock issued and outstanding as of June 30, 2017 and December 31, 2016, respectively.

 

Note 9 — Stock Warrants

  

A summary of the various changes in warrants during the six month period ended June 30, 2017 is as follows:

 

   Number of
Warrants
 
     
Warrants Outstanding at December 31, 2016   401,859 
Exercised During the Period   (250,009)
Issued During the Period    
Expired During the Period    
      
Warrants Outstanding, June 30, 2017   151,850 

 

The outstanding warrants as of June 30, 2017 expire from November 3, 2017 to August 5, 2018. The weighted average remaining term of the warrants is 0.9 years. The weighted average exercise price is $2.66 per share.

  

Note 10 — Stock Based Compensation Plans

 

A summary of stock option activity for the six months ended June 30, 2017 is as follows:

 

    Number of
Options
   Weighted
Average
Exercise
Price
 
     
Outstanding at December 31, 2016   1,084,298   $4.76 
Granted   362,000    5.87 
Exercised   (35,375)   2.40 
Expired or Forfeited   (25,432)   8.16 
           
Outstanding at June 30, 2017   1,385,491   $4.97 

 

13 

 

 

The weighted average remaining contractual term for all options as of June 30, 2017 and December 31, 2016 was 7.8 years and 7.6 years respectively.

 

As of June 30, 2017, there were 675,464 options that were fully vested and exercisable at a weighted average exercise price of $4.57 per share. The weighted average remaining contractual term on the vested options is 6.5 years.

  

As of June 30, 2017, there were 710,027 unvested options exercisable at a weighted average exercise price of $5.34 per share. The weighted average remaining contractual term on the unvested options is 8.9 years.

 

No cash was received from option exercises for the six months ended June 30, 2017.

  

The weighted average fair value of option grants was calculated using the Black-Scholes-Merton option pricing method. At June 30, 2017, the Company had approximately $2,942,000 of unrecognized stock compensation expense, which will be recognized over a weighted average period of approximately 3.1 years.

 

During the six months ended June 30, 2017, the Company issued 100,000 shares of non-vested stock to an executive officer which vest over four years. The fair market value on the date of grant of the non-vested stock issued during the six months ended June 30, 2017 was $5.90, resulting in an aggregate fair value of $590,000. As of June 30, 2017, there was $565,000 of unrecognized compensation cost related to unvested stock awards. This amount is expected to be recognized over a weighted-average period of 3.8 years.

 

For the three months ended June 30, 2017 and 2016, the Company recorded total stock compensation expense of approximately $277,000 and $175,000, respectively. For the six months ended June 30, 2017 and 2016, the Company recorded total stock compensation expense of approximately $487,000 and $349,000, respectively.

 

Note 11 — Litigation

  

We are not currently involved in any pending legal proceeding or litigation.

 

Note 12 — Contractual Obligations

 

The Company is party to several lease agreements, with the largest being for its office and manufacturing space under an operating lease that commenced October 3, 2015, that expires on October 3, 2020. The Company also leases small office spaces in England under a two-year lease and under a one year lease arrangement in Japan.

 

Future minimum payments required under operating lease obligations as of June 30, 2017 are as follows:

 

   

Total

Minimum

Lease

Payments

 
2017 (6 months remaining)     183,604  
2018     339,910  
2019     335,248  
2020     307,311  
2021     -  
Total   $ 1,166,073  

  

Under the lease agreements described above, the Company is required to pay the pro rata share of the real property taxes and assessments, expenses and other charges associated with these facilities.

 

Rent expense for the six months ended June 30, 2017 and 2016 totaled $228,509 and $246,704, respectively.

 

14 

 

 

Note 13 — Recent Accounting Pronouncements

 

 In May 2014, the FASB issued ASU 2014-09, “Revenue from Contracts with Customers,” which supersedes the revenue recognition requirements in “Revenue Recognition (Topic 605),” and requires an entity to recognize revenue in a way that depicts the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. ASU 2014-09 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2017. The Company has the option to apply the provisions of ASU 2014-09 either retrospectively to each prior reporting period presented or retrospectively with the cumulative effect of initially applying the new guidance recognized at the date of initial application (the modified retrospective transition method). We are currently evaluating the alternative methods of adoption and the effect of adopting ASU 2014-09 on our financial statements and related disclosures. We anticipate electing to adopt the standard using the modified retrospective transition method as of January 1, 2018. However, this election may change as we finalize our analysis of the impact of the provisions of ASU 2014-09 on the Company. We are also in the process of assessing which of our operating revenue streams will be impacted by the adoption of the new standard and its impact on the consolidated financial statements.

 

In February 2016, the FASB issued Accounting Standards Update ASU 2016-02 Leases (Topic 842). Current US generally accepted accounting principles (GAAP) requires lessees and lessors to classify leases as either capital leases or operating leases, where lessees recognize assets and liabilities for capital leases but not for operating leases. ASU 2016-02 requires lessees to recognize assets and liabilities for all leases (with an exception for short-term leases). The new FASB guidance will be effective for fiscal years beginning after December 15, 2018, and interim periods thereafter. The Company is currently evaluating the impact the adoption of this standard will have on the consolidated financial statements.

 

 Accounting Pronouncements Adopted in Q1 2017

 

In March 2016, the FASB issued ASU No. 2016-09 Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting which amends the current stock compensation guidance. The amendments simplify the accounting for the taxes related to stock based compensation, including adjustments to how excess tax benefits and a company's payments for tax withholdings should be classified. Under this new guidance, entities must elect whether to account for forfeitures of share-based payments by (1) recognizing forfeitures of awards as they occur or (2) apply an estimated forfeiture rate, as is currently required. The standard is effective for fiscal periods beginning after December 15, 2016. We have adopted this standard for the quarter ended March 31, 2017 and have elected to account for forfeitures as they occur. The adoption of this standard did not have a material impact on our consolidated financial statements.

 

In November 2015, the FASB issued Accounting Standards Update (“ASU”) No. 2015-17, Income Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes. ASU 2015-17 simplifies the presentation of deferred income taxes by requiring that deferred tax liabilities and assets be classified as noncurrent in a classified statement of financial position. The standard is effective for financial statements issued for annual periods beginning after December 15, 2016, and interim periods within those annual periods and may be applied either prospectively to all deferred tax liabilities and assets or retrospectively to all periods presented. We have adopted this standard for the quarter ended March 31, 2017 on a prospective basis; therefore, all deferred tax assets and liabilities have been classified as noncurrent in the accompanying Consolidated Balance Sheets. Noncurrent deferred tax assets and noncurrent deferred tax liabilities are included in other assets and other long-term liabilities, respectively, in the accompanying Consolidated Balance Sheets.  As of March 31, 2017, the Company had a full valuation allowance against all net deferred tax assets, as such the adoption of this standard did not have a material impact on our consolidated financial statements.

 

There are no other recent accounting pronouncements that we expect to have a material impact on the consolidated financial statements.

 

15 

 

 

Note 14 — Subsequent Events  

 

 Recent Stock Awards:

 

Since June 30, 2017, the Company has awarded 50,000 common shares, to its external board members as part of their annual retainer for services covering July 2017 to June 2018.

 

Recent Stock Option Awards:

 

Since June 30, 2017, the Company has awarded 65,500 stock options to employees, subject to vesting terms.

 

Sale of Common Stock:

 

On August 9, 2017, the Company entered into agreements to sale 1,500,000 shares of common stock, at an offering price of $5.75 per share. Total gross proceeds from the offering will be $8,625,000, before commissions and offering expenses. The offering is expected to close on August 14, 2017.

 

16 

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

You should read the following discussion and analysis of financial condition and results of operations in conjunction with the financial statements and related notes appearing elsewhere in this quarterly report and in our annual report on Form 10-K for the year ended December 31, 2016.

 

As used in this report, unless otherwise indicated, the terms “Company,” “Vuzix” “management,” “we,” “our,” and “us” refer to Vuzix Corporation and its subsidiary.

 

Critical Accounting Policies and Significant Developments and Estimates

 

The discussion and analysis of our financial condition and results of operations are based on our unaudited condensed consolidated financial statements and related notes appearing elsewhere in this quarterly report. The preparation of these statements in conformity with generally accepted accounting principles requires the appropriate application of certain accounting policies, many of which require us to make estimates and assumptions about future events and their impact on amounts reported in our financial statements, including the statement of operations, balance sheet, cash flow and related notes. We continually evaluate our estimates used in the preparation of our financial statements, including those related to revenue recognition, bad debts, inventories, warranty reserves, product warranty, carrying value of long-lived assets, fair value measurement of financial instruments and embedded derivatives, valuation of stock compensation awards, and income taxes. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about carrying values of assets and liabilities that are not apparent from other sources. Since future events and their impact cannot be determined with certainty, the actual results will inevitably differ from our estimates. Such differences could be material to the financial statements.

 

We believe that our application of accounting policies, and the estimates inherently required therein, are reasonable. We periodically reevaluate these accounting policies and estimates, and make adjustments when facts and circumstances dictate a change. Historically, we have found our application of accounting policies to be appropriate, and actual results have not differed materially from those determined using necessary estimates.

 

Management believes certain factors and trends are important in understanding our financial performance. The critical accounting policies, judgments and estimates that we believe have the most significant effect on our financial statements are:

 

  valuation of inventories;
  carrying value of long-lived assets;
  software development costs;
  revenue recognition;
  product warranty;
  fair value measurement of financial instruments and embedded derivatives;
  stock-based compensation; and
  income taxes.

 

Our accounting policies are more fully described in the notes to our condensed consolidated financial statements included in this quarterly report and in our annual report on Form 10-K for the year ended December 31, 2016. There have been no significant changes in our accounting policies for the six month period ended June 30, 2017.

 

Off Balance Sheet Arrangements

 

We do not have any off-balance sheet arrangements that have, or are reasonably likely to have, an effect on our financial condition, financial statements, revenues or expenses.

 

17 

 

 

 

Business Matters

 

We are engaged in the design, manufacture, marketing and sale of wearable display devices also referred to as head mounted displays (or HMDs), in the form of Augmented Reality (AR) glasses, Virtual Reality (VR) glasses and Smart Glasses. Our wearable display products are referred to as Video Eyewear, head mounted wearable displays, video glasses, personal viewers, near-eye virtual displays, and near-eye displays or NEDs. Our wearable display products provide virtual large high-resolution screens, fit in a user’s pocket or purse and can be viewed practically anywhere, anytime. They can also be used for VR and AR applications, in which the wearer is either immersed in a computer generated world or has their real world view augmented with computer generated information or graphics. We produce and sell two main types of wearable display products: Smart Glasses for a variety of enterprise and commercial users and applications, including AR; and Video Viewing glasses, for on-the-go users as mobile displays for entertainment and gaming, as well as support for stepping into virtual worlds, simulations, and VR gaming. Our products are available with varying features, including with and without application running computer processors, and are offered as either monocular or binocular display systems.

 

With respect to our Smart Glasses and AR products we are focused on the enterprise, industrial, commercial, and medical markets while our Video Eyewear products are sold in the consumer markets and are targeted at applications including video viewing, gaming and VR. All of the mobile display and mobile electronics space in which we compete have been subject to rapid technological change over the last decade including the rapid adoption of tablets, larger screen sizes and display resolutions along with declining prices on mobile phones and other computing devices, and as a result we must continue to improve our products’ performance and lower our costs. We believe our intellectual property portfolio gives us a leadership position in microdisplay projection engines, waveguides, ergonomics, packaging, and optical systems.

   

18 

 

  

Recent Accounting Pronouncements

  

In May 2014, the FASB issued ASU 2014-09, “Revenue from Contracts with Customers,” which supersedes the revenue recognition requirements in “Revenue Recognition (Topic 605),” and requires an entity to recognize revenue in a way that depicts the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. ASU 2014-09 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2017. The Company has the option to apply the provisions of ASU 2014-09 either retrospectively to each prior reporting period presented or retrospectively with the cumulative effect of initially applying the new guidance recognized at the date of initial application (the modified retrospective transition method). We are currently evaluating the alternative methods of adoption and the effect of adopting ASU 2014-09 on our financial statements and related disclosures. We anticipate electing to adopt the standard using the modified retrospective transition method as of January 1, 2018. However, this election may change as we finalize our analysis of the impact of the provisions of ASU 2014-09 on the Company. We are also in the process of assessing which of our operating revenue streams will be impacted by the adoption of the new standard and its impact on the consolidated financial statements.

 

In February 2016, the FASB issued Accounting Standards Update ASU 2016-02 Leases (Topic 842). Current US generally accepted accounting principles (GAAP) requires lessees and lessors to classify leases as either capital leases or operating leases, where lessees recognize assets and liabilities for capital leases but not for operating leases. ASU 2016-02 requires lessees to recognize assets and liabilities for all leases (with an exception for short-term leases). The new FASB guidance will be effective for fiscal years beginning after December 15, 2018, and interim periods thereafter. The Company is currently evaluating the impact the adoption of this standard will have on the consolidated financial statements.

 

  Accounting Pronouncements Adopted in Q1 2017

 

In March 2016, the FASB issued ASU No. 2016-09 Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting which amends the current stock compensation guidance. The amendments simplify the accounting for the taxes related to stock based compensation, including adjustments to how excess tax benefits and a company's payments for tax withholdings should be classified. Under this new guidance, entities must elect whether to account for forfeitures of share-based payments by (1) recognizing forfeitures of awards as they occur or (2) apply an estimated forfeiture rate, as is currently required. The standard is effective for fiscal periods beginning after December 15, 2016. We have adopted this standard for the quarter ended March 31, 2017 and have elected to account for forfeitures as they occur. The adoption of this standard did not have a material impact on our consolidated financial statements.

 

In November 2015, the FASB issued Accounting Standards Update (“ASU”) No. 2015-17, Income Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes. ASU 2015-17 simplifies the presentation of deferred income taxes by requiring that deferred tax liabilities and assets be classified as noncurrent in a classified statement of financial position. The standard is effective for financial statements issued for annual periods beginning after December 15, 2016, and interim periods within those annual periods and may be applied either prospectively to all deferred tax liabilities and assets or retrospectively to all periods presented. We have adopted this standard for the quarter ended March 31, 2017 on a prospective basis; therefore, all deferred tax assets and liabilities have been classified as noncurrent in the accompanying Consolidated Balance Sheets. Noncurrent deferred tax assets and noncurrent deferred tax liabilities are included in other assets and other long-term liabilities, respectively, in the accompanying Consolidated Balance Sheets.  As of March 31, 2017, the Company had a full valuation allowance against all net deferred tax assets, as such the adoption of this standard did not have a material impact on our consolidated financial statements.

 

There are no other recent accounting pronouncements that we expect to have a material impact on the consolidated financial statements.

 

19 

 

 

Results of Operations

 

Comparison of Three Months Ended June 30, 2017 and June 30, 2016

 

The following table compares the Company’s consolidated statements of operations data for the three months ended June 30, 2017 and 2016.

 

   3 Months Ended June 30, 
   2017   2016   Dollar Change   % Increase  
(Decrease)
 
                 
Sales of Products  $904,947   $421,377   $483,570    115%
Sales of Engineering Services   420,314    139,500    280,814    201%
                     
Total Sales   1,325,261    560,877    764,384    136%
                     
Cost of Sales — Products   1,397,831    647,871    749,960    116%
Cost of Sales — Engineering Services   356,917    39,060    317,857    814%
                     
Total Cost of Sales   1,754,748    686,931    1,067,817    155%
                     
Gross Loss (exclusive of depreciation shown separately below)   (429,487)   (126,054)   (303,432)   (241)%
Gross Loss %   (32)%   (22)%          
                     
Operating Expenses:                    
Research and Development   1,198,940    1,669,043    (470,103)   (28)%
Selling and Marketing   800,329    651,547    148,535    23%
General and Administrative   1,308,234    1,199,427    108,797    9%
Depreciation and Amortization   242,979    183,686    59,293    32%
                     
Loss from Operations   (3,979,969)   (3,829,757)   (150,211)   4%
                     
Other Income (Expense)                    
Investment Income   14,944    3,324    11,620    350%
Other Taxes   (11,600)   (13,904)   2,304    (17)%
Foreign Exchange Loss   (26,151)   (3,536)   (22,615)   640%
Loss on Derivative Valuation   (13,416)   (99,679)   86,263    (87)%
Amortization of Senior Term Debt Discount   (21,568)   (114,816)   93,248    (81)%
Amortization of Deferred Financing Costs   (8,048)   (11,580)   3,532    (31)%
Interest Expense   (24,291)   (33,542)   9,251    (28)%
                     
Total Other Expense   (90,130)   (273,733)   183,603    (67)%
                     
Loss Before Provision for Income Taxes   (4,070,099)   (4,103,490)   (33,391)   (-1)%
Provision for Income Taxes                
                     
Net Loss  $(4,070,099)  $(4,103,490)  $(33,391)   (-1)%

  

20 

 

 

 Sales.    There was an overall increase in sales for the quarter ended June 30, 2017 over the same period in 2016 of $764,384 or 136%. The following table reflects the major components of our sales:

 

   Quarter Ended
June 30,
2017
   % of
Sales
   Quarter Ended
June 30,
2016
   % of
Sales
   Dollar Change   % Increase
(Decrease)
 
                         
Sales of Smart Glasses  $707,920    53%  $286,933    51%  $420,987    147%
Sales of Video Eyewear   68,988    5%   54,168    10%   14,820    27%
Sales of Waveguides   116,305    9%   65,000    12%   51,305    79%
Sales Freight out   11,734    1%   15,276    2%   (3,542)   (23)%
Sales of Engineering Services   420,314    32%   139,500    25%   280,814    201%
Total Sales  $1,325,261    100%  $560,877    100%  $764,384    136%

 

 The increase in Smart Glasses sales was primarily the result of increased M300 shipments in the second quarter of 2017 as compared to no sales in the corresponding second quarter of 2016, a period when the M300 was not available for sale. Sales of our original M100 Smart Glasses decreased in the second quarter of 2017 over the 2016 quarterly period, reflecting the growing sales strength of the new M300. Our iWear Video Headphones sales were up 27% for the second quarter of 2017 as compared to the same period in 2016. This overall revenue increase was achieved even after our drop in the retail price of the iWear to $299 from its 2016 price of $499. Sales of Waveguide systems in the 2017 period were related to two new programs with tier-1 consumer electronics firms, as compared to the 2016 comparative period when only one Waveguide related program took place. Sales of engineering services increased 201% over the same period in 2016, entirely due to our ongoing work on the Toshiba smart glasses development program announced in February 2017. The amount recorded for the three months ending June 30, 2017, represents accrued billings recognized on a percentage of completion basis.

 

Cost of Sales and Gross Loss. Cost of product revenues and engineering services is comprised of materials, components, labor, warranty costs, freight costs, manufacturing overhead, software royalties, and the non-cash amortization of software development costs related to the production of our products and rendering engineering services. The following table reflects the components of our cost of goods sold for products:

 

Component of Cost of Sales  Quarter Ended
June 30,
2017
   As %
Related Product
Sales
   Quarter Ended
June 30,
2016
   As % of
Related Product
Sales
   Dollar
Change
   % Increase (Decrease)  
                          
Product Cost of Sales  $437,867    48%  $170,839    41%  $267,028   156 %
Freight Costs   128,118    14%   147,940    35%   (19,822)  (13 )%
Manufacturing Overhead   208,599    23%   168,977    40%   39,622   23 %
Warranty Costs   54,541    6%   12,249    3%   42,292   345 %
Inventory Obsolescence   473,324    52%   44,220    11%   429,104   970 %
Amortization of Software Costs   71,613    8%   71,613    17%   -   -
Software Royalties   23,769    3%   32,033    8%   (8,264)  (26 )%
                               
Total Cost of Sales – Products  $1,397,831    154%  $647,871    154%  $749,960   116 %
                             
Gross Loss – Product Sales  $(492,884)   (54)%  $(226,494)   (54)%  $(266,390)  117 %

 

 For the second quarter ended June 30, 2017 we reported a larger gross loss from product sales as compared to the prior year. On a direct product cost of sales basis only, product direct costs rose to 48% of sales versus 41% in the prior year’s period. These costs as a percentage of sales were negatively impacted due to the near zero margin being earned on our written down iWear Video Headphones sales, which are now effectively being sold at their net realizable value, pursuant to our write-down at end of fiscal 2016, as well as higher M300 manufacturing costs through half the second quarter of 2017 before its move to China. During the second quarter ended June 30, 2017, we reported a large increase in the inventory obsolescence provisions related to our M300 smart glasses production runs and the move from our contract manufacturer’s California site to their China facility. Further obsolescence provisions resulted from cable and component quality issues, and lower initial production yields of the M300 and its accessories, some of which were deemed not saleable.

 

Costs for engineering services accrued for the three months ended June 30, 2017 represent direct project costs as well as the reclassification of internal research and development wage costs related to the Toshiba engineering program, plus accruals for the expected overall program’s completion costs as a percentage of accrued revenues.

 

21 

 

 

Research and Development.   Our research and development expenses consist primarily of compensation costs for personnel, related stock compensation expenses, third party services, purchase of research supplies and materials, and consulting fees related to research and development costs. Software development expenses to determine technical feasibility before final development and ongoing maintenance are not capitalized and are included in research and development costs.

 

   Quarter Ended
June 30,
2017
   % of
Sales
   Quarter Ended
June 30,
2016
   % of
Sales
   Dollar Change   % Increase
(Decrease)
 
                               
Research and Development  $1,198,940    90%  $1,669,043    298%  $(470,103)   (28)%

 

Comparing the major net reductions in our research and development costs for the quarter ended June 30, 2017 versus the same period in 2016, there was an increase in 2017 salary, benefits and stock compensation expenses of $136,549, primarily the result of additional R&D staff versus the same period in 2016; a $178,269 reclass of internal salary costs to cost of sales for engineering services related to the Toshiba engineering services project; of a decrease in project development and research costs of $369,769 as compared to the 2016 period when the M300 Smart Glasses were still in development internally and with our outside contractors which assisted in the development work; and a decrease of $16,307 in travel costs related to our outside production contractor and development contractors.

 

 Selling and Marketing.    Selling and marketing costs consist of trade show costs, advertising, sales samples, travel costs, sales staff compensation costs including stock compensation expense, consulting fees, public relations agency fees, website costs and sales commissions paid to full-time staff and outside consultants.

  

   Quarter Ended
June 30,
2017
   % of
Sales
   Quarter Ended
June 30,
2016
   % of
Sales
   Dollar Change   % Increase
(Decrease)
 
                               
Selling and Marketing  $800,329    60%  $651,547    116%  $148,782    23%

 

These costs increased overall due to the following factors: an increase of $220,432 in product sales samples and developer units reflecting a special marketing push on our new M300; a $34,740 increase in salary, commissions, benefits and stock compensation expenses related to new staff additions in Europe as compared to the same period in 2016; an increase of $11,722 for computer software subscriptions; offset by a reduction of $60,623 in trade show costs; a reduction of $37,498 in website related costs, and a $32,365 decrease in travel costs.

 

General and Administrative.   General and administrative costs include professional fees, investor relations (IR) costs including shares and warrants issued for IR services, salaries and related stock compensation, travel costs, office and rental costs.

 

   Quarter Ended
June 30,
2017
   % of
Sales
   Quarter Ended
June 30,
2016
   % of
Sales
   Dollar Change   % Increase
(Decrease)
 
                               
General and Administrative  $1,308,234    99%  $1,199,427    214%  $108,807    9%

 

22 

 

 

General and administrative costs rose by 9% or $108,807 for the second quarter of 2017 versus the 2016 period primarily because of: increased salary and stock compensation costs of $302,046 due to the hiring of new accounting and internal IR personnel and the Company’s new COO; an increase of $38,275 in hiring expenses for new accounting staff; offset by a reduction of $37,934 in legal costs; a reduction of $47,573 for Sarbanes-Oxley Section 404 consultants retained to assist management in designing and implementing improvements in our financial reporting controls; and a reduced spending of $172,878 on investor relations activities.

 

Depreciation and Amortization.   Depreciation and amortization expense for the three months ended June 30, 2017 was $242,979, as compared to $183,686 in the same period in 2016, an increase of $59,293. The increase in depreciation and amortization expense is due to new investments in depreciable assets made during 2016 and the first half of 2017.

 

Other Income (Expense).  Total other expense was $90,130 for the three months ended June 30, 2017 compared to an expense of $273,733 in the same period in 2016, a decrease of $183,603. The overall decrease in these other expenses was primarily the result of a reduced loss on the derivative valuation for the three months ended June 30, 2017 of $13,416 as compared to a loss of $99,679 in the same period in 2016, a decrease of $86,263; and reduced amortization of senior term debt discounts and deferred financing costs and a related reduction in interest expense, the direct result in conversions of the debt and their maturity on June 4, 2017.

 

Provision for Income Taxes. There was not a provision for income taxes in the three month period ending June 30, 2017 or 2016.

 

Comparison of Six Months Ended June 30, 2017 and June 30, 2016

 

The following table compares the Company’s consolidated statements of operations data for the six months ended June 30, 2017 and 2016.

 

   6 Months Ended June 30, 
   2017   2016   Dollar Change   % Increase  
(Decrease)
 
                 
Sales of Products  $1,864,330   $785,217   $1,079,113    137%
Sales of Engineering Services   671,594    139,500    532,094    381%
                     
Total Sales   2,535,924    924,717    1,611,207    174%
                     
Cost of Sales — Products   2,351,734    1,250,848    1,100,886    88%
Cost of Sales — Engineering Services   464,917    39,060    425,857    1,090%
                     
Total Cost of Sales   2,816,651    1,289,908    1,526,743    118%
                     
Gross Loss (exclusive of depreciation shown separately below)   (280,727)   (365,191)   84,464    (23)%
Gross Loss %   (11)%   (39)%          
                     
Operating Expenses:                    
Research and Development   2,867,748    2,943,756    (76,008)   (3)%
Selling and Marketing   1,831,328    1,778,046    53,282    3%
General and Administrative   2,543,417    2,085,744    457,673    22%
Depreciation and Amortization   482,809    352,874    129,935    37%
                     
Loss from Operations   (8,006,029)   (7,525,611)   (480,418)   6%
                     
Other Income (Expense)                    
Investment Income   32,844    12,779    20,065    157%
Other Taxes   (22,150)   (34,625)   12,475    (36)%
Foreign Exchange Loss   (25,053)   (7,484)   (17,569)   235%
Gain (Loss) on Derivative Valuation   9,144    1,987    7,157    360%
Amortization of Senior Term Debt Discount   (155,760)   (236,022)   80,262    (34)%
Amortization of Deferred Financing Costs   (19,500)   (23,160)   3,660    (16)%
Interest Expense   (65,258)   (67,093)   1,835    (3)%
                     
Total Other Expense   (245,733)   (353,618)   107,885    (31)%
                     
Loss Before Provision for Income Taxes   (8,251,762)   (7,879,229)   (372,533)   5%
Provision for Income Taxes                
                     
Net Loss  $(8,251,762)  $(7,879,229)  $(372,533)   5%

   

23 

 

 

 Sales.    There was an overall increase in total revenue for the six months ended June 30, 2017 over the same period in 2016 of $1,611,207 or 174%. The following table reflects the major components of our sales:

 

   6 Months Ended
June 30,
2017
   % of
Sales
   6 Months Ended
June 30,
2016
   % of
Sales
   Dollar Change   % Increase
(Decrease)
 
                         
Sales of Smart Glasses  $1,609,368    63%  $599,097    65%  $1,010,271    169%
Sales of Video Eyewear   117,307    5%   96,148    10%   21,159    22%
Sales of Waveguides   116,305    5%   65,000    7%   51,305    79%
Sales Freight out   21,350    1%   24,972    3%   (3,622)   (15)%
Sales of Engineering Services   671,594    26%   139,500    15%   532,094    381%
Total Sales  $2,535,924    100%  $924,717    100%  $1,611,207    174%

 

 The increase in Smart Glasses sales was primarily the result of the volume production release and commencement of sales of the M300 Smart Glasses. M300 sales contributed to the majority of increased revenues in the first half of 2017 as compared to no sales in the corresponding first half of 2016, a period when the M300 was not available for sale other than by pre-order. Sales of our original M100 Smart Glasses decreased in 2017 over the same 2016 first half period. Our iWear Video Headphones sales were up 22% for the 6 months ended June 30, 2017 as compared to the same period in 2016. This overall revenue increase was achieved even after our drop in the retail price of the iWear to $299 from its 2016 price of $499. Sales of waveguide systems in the 2017 period were related to two new programs with tier-1 consumer electronics firms. Sales of engineering services rose $532,094 in the first half of 2017 versus the same period in 2016, entirely due to work on the Toshiba smart glasses development program commenced in February 2017.  The amount recorded for the six months ending June 30, 2017, represents accrued billings recognized on a percentage of completion basis.

 

Cost of Sales and Gross Loss. Cost of product revenues and engineering services is comprised of materials, components, labor, warranty costs, freight costs, manufacturing overhead, software royalties, and the non-cash amortization of software development costs related to the production of our products and rendering engineering services. The following table reflects the components of our cost of goods sold for products:

 

Component of Cost of Sales  6 Months Ended
June 30,
2017
   As %
Related Product
Sales
   6 Months Ended
June 30,
2016
   As % of
Related Product
Sales
   Dollar
Change
   % Increase
(Decrease)
 
                         
Product Cost of Sales  $943,767    51%  $245,025    31%  $698,742    285%
Freight Costs   229,703    12%   214,954    27%   14,749    7%
Manufacturing Overhead   433,636    23%   316,038    40%   117,598    37%
Warranty Costs   92,189    5%   23,168    3%   69,021    298%
Inventory Obsolescence   458,252    25%   253,350    32%   204,902    81%
Amortization of Software Costs   143,225    8%   143,225    18%   -    -
Software Royalties   50,962    3%   55,088    7%   (4,126)   (8)%
                               
Total Cost of Sales – Products  $2,351,734    126%  $1,250,848    159%  $1,100,886    88%
                               
Gross Loss – Product Sales  $(487,404)   (26)%  $(465,631)   (59)%  $(21,773)   5%

 

  For the six months ended June 30, 2017, we reported a larger gross loss from product sales as compared to the prior year’s period. On a direct product cost of sales only basis, product direct costs rose to 51% of sales for the first 6 months of 2017 versus 31% for the same period in 2016. These costs as a percentage of sales were negatively impacted due to the near zero margin being earned on our written down iWear Video Headphones sales, which are now effectively being sold at their net realizable value, pursuant to our write-down at end of fiscal 2016, as well as higher M300 manufacturing costs, a product not offered in the 2016 comparative period. During the six month period ended June 30, 2017, we reported a large in increase in the inventory obsolescence provisions related to our M300 smart glasses production runs and the move from our contract manufacturer’s California site to their China facility. Further obsolescence provisions resulted from cable and component quality issues, and lower initial production yields of the M300 and its accessories, some of which were deemed not saleable. Manufacturing Overhead costs rose as a result of additional staff in the QA and purchasing areas over the 2016 period.

 

Costs for engineering services accrued for the six months ended June 30, 2017 represent direct project costs as well as the reclassification of internal research and development wage costs related to the Toshiba engineering program, plus accruals for the expected overall program’s completion costs as a percentage of accrued revenues.

 

24 

 

 

Research and Development.   Our research and development expenses consist primarily of compensation costs for personnel, related stock compensation expenses, third party services, purchase of research supplies and materials, and consulting fees related to research and development costs. Software development expenses to determine technical feasibility before final development and ongoing maintenance are not capitalized and are included in research and development costs.

 

   6 Months Ended
June 30,
2017
   % of
Sales
   6 Months Ended
June 30,
2016
   % of
Sales
   Dollar Change   % Increase
(Decrease)
 
                               
Research and Development  $2,867,748    113%  $2,943,756    318%  $(76,008)   (3)%

  

Comparing the overall decrease in research and development costs for the six months ended June 30, 2017 versus the same period in 2016: there was an increase in 2017 salary, benefits and stock compensation expenses of $243,737, primarily the result of additional R&D staff versus the same period in 2016; a $178,269 reclass of internal salary costs to cost of sales for engineering services related to the Toshiba engineering services project; a decrease in project development and research costs of $38,118 primarily related to reduced M300 Smart Glasses development work year over year offset by increased development work on a waveguide products and related technology; and a decrease of $48,388 in travel costs related to our outside production contractor and development contractors.

 

 Selling and Marketing.    Selling and marketing costs consist of trade show costs, advertising, travel costs, sales staff compensation costs including stock compensation expense, consulting fees, public relations agency fees, website costs and sales commissions paid to full-time staff and outside consultants.

 

   6 Months Ended
June 30,
2017
   % of
Sales
   6 Months Ended
June 30,
2016
   % of
Sales
   Dollar Change   % Increase
(Decrease)
 
                               
Selling and Marketing  $1,831,328    72%  $1,778,046    192%  $53,282    3%

 

 These costs increased overall due to the following factors: an increase of $202,622 in product sales samples and developer units reflecting a special marketing push on our new M300; a $93,284 increase in salary and consultant fees, commissions, benefits and stock compensation expenses related to new staff and full-time consultant additions in Europe as compared to the same period in 2016; an increase of $30,348 for computer software subscriptions; offset by a reduction of $138,347 in website costs; a reduction of $41,859 in travel costs; and a reduction of $103,838 in marketing firm services.

 

General and Administrative.   General and administrative costs include professional fees, investor relations (IR) costs including shares and warrants issued for IR services, salaries and related stock compensation, travel costs, office and rental costs.

 

   6 Months Ended
June 30,
2017
   % of
Sales
   6 Months Ended
June 30,
2016
   % of
Sales
   Dollar Change   % Increase
(Decrease)
 
                               
General and Administrative  $2,543,417    100%  $2,085,744    226%  $457,673    22%

 

25 

 

 

General and administrative costs rose for the first six months of 2017 versus 2016 primarily because of: increased salary and stock compensation costs of $391,692 due to the hiring of new accounting and internal IR personnel and the Company’s new COO; an increase of $38,431 in hiring expenses for new accounting staff; a $28,029 increase in IT consulting fees; a $99,428 increase in auditor fees; and an increase of $52,471 for Sarbanes-Oxley Section 404 consultants retained to assist management in designing and implementing improvements in our financial reporting; partially offset by reductions of $33,491 in legal costs; and reduced spending of $162,323 for investor relations activities.

 

Depreciation and Amortization.   Depreciation and amortization expense for the six months ended June 30, 2017 was $482,809 as compared to $352,874 in the same period in 2016, an increase of $129,935. The increase in depreciation and amortization expense is due to new investments in depreciable assets made during 2016 and the first half of 2017.

 

Other Income (Expense).  Total other expense was $245,733 for the six months ended June 30, 2017 compared to an expense of $353,618 in the same period in 2016, a decrease of $107,885. The overall decrease in these other expenses was primarily the result of a reduced amortization of the senior term debt discount and financing costs of $83,922, the direct result of conversions, and an increase of $20,065 in investment income for the six months ended June 30, 2017 as compared to the same period in 2016.

 

Provision for Income Taxes. There was not a provision for income taxes in the six month period ending June 30, 2017 or 2016.  

 

Liquidity and Capital Resources

 

 As of June 30, 2017, we had cash and cash equivalents of $6,129,342, a decrease of $8,404,602 from $14,533,944 as of December 31, 2016.

 

At June 30, 2017, we had current assets of $10,822,987 compared to current liabilities of $3,062,638 which resulted in a positive working capital position of $7,760,349. At December 31, 2016, we had a working capital position of $13,808,094. Our current liabilities are comprised principally of accounts payable and accrued expenses.

 

Operating Activities. We used $7,548,842 of cash for operating activities for the six months ending June 30, 2017 and $6,387,140 in the same period in 2016. The major operating items for the six month period ended June 30, 2017 resulted from a $6,873,010 loss from operations after non-cash adjustments, and a $420,314 increase in accrued revenue, a $755,923 increase in net inventory, a $279,898 decrease in prepaid expenses, a $723,632 increase in accounts payable, a $370,534 reduction in unearned revenue, and a $124,918 reduction in accrued compensation. The major operating items for the comparative six month period ended 2016 resulted from a $6,601,055 loss from operations after non-cash adjustments and changes in operating assets and liabilities for 2016 resulted from a $210,899 increase in prepaid expenses, a $223,811 decrease in accounts receivable and a $149,734 increase in accounts payable.

 

Investing Activities.   Cash used in investing activities was $855,760 for the six months ended June 30, 2017 as compared to $893,375 in the same period in 2016. During the first six months of 2017, $662,993 was used primarily for the purchase of manufacturing equipment, product mold tooling, and computer equipment as compared to spending of $836,541 for the same period in 2016. During the first six months of 2017, a total of $100,000 in software development costs related to our new smart glasses application product was capitalized, versus $-0- for the same period in 2016 when no amounts were capitalized. The costs of registering our intellectual property rights, included in the investing activities totals described above, were $92,767 in the six month period ending June 30, 2017 and $56,834 in the same period in 2016.

 

Financing Activities.   We used zero cash for financing activities for the six months ending June 30, 2017 as compared to $10,210 in the same period in 2016.

 

26 

 

 

  Capital Resources.   As of June 30, 2017, we had a cash balance of $6,129,342.

 

We incurred a net loss for the first six months of 2017 of $8,251,762. The Company incurred annual net losses of $19,250,082 in 2016 and $13,427,478 in 2015, and has an accumulated deficit of $85,090,712 as of June 30, 2017. The Company needs to grow its business significantly to become profitable and self-sustaining on a cash flow basis or it will be required to raise new capital. The Company’s management intends to take actions necessary to continue as a going concern, and accordingly our condensed consolidated financial statements included in this report have been prepared assuming that we will continue as a going concern. This basis of accounting contemplates the recovery of our assets and the satisfaction of liabilities in the normal course of business. These condensed consolidated financial statements do not include any adjustments to the specific amounts and classifications of assets and liabilities, which might be necessary should we be unable to continue as a going concern.

 

The Company’s cash requirements related to funding operating losses depend on numerous factors, including new product development activities, our ability to commercialize our products, their timely market acceptance, selling prices and gross margins, and other factors. In order for us to achieve positive cash flow from operations, our product sales will need to increase significantly. Late in the first half of 2017, the Company began volume production and commercial shipments of its new M300 Smart Glasses, after a longer and more costly planned development, expanding its product offerings from the prior 2016 period, when the M300 was announced but not ready for sale. However, if this product and others in development are not successful within a reasonably short period of time period after their commercial releases, we will have to raise additional capital to maintain operations and/or materially reduce our operating and new product development costs.

 

Historically, the Company has met its cash needs by the sales of equity and convertible debt, and borrowings under notes. If the Company raises additional funds by these methods, the ownership interest of existing shareholders may be diluted. The amount of such dilution could increase due to the issuance of new warrants or securities with other dilutive characteristics, such as full ratchet anti-dilution clauses or price resets. The Company saw all of its senior debt converted into common stock, prior to its maturity June 3, 2017. As of June 30, 2017, the Company has no secured debts outstanding.

 

On August 9, 2017, the Company entered into agreements to sale 1,500,000 shares of common stock, at an offering price of $5.75 per share. Total gross proceeds from the offering will be $8,625,000, before commissions and offering expenses. The offering is expected to close on August 14, 2017.We believe our existing cash and cash equivalent balances, along with the proceeds of our recently announced offering, and cash flow from future operations should, if management’s operating plan is met, be sufficient to meet our working capital and capital expenditure needs for the foreseeable future even with continued, but reduced operating losses for the next two quarters. It is likely we will have to raise additional capital to maintain operations and/or materially reduce our operating and new product development costs over the next 12 months. There can, however, be no assurance that we will be able to meet our operating plan for the next 12 months and that we will be able to generate positive cash flows from operations in the future thereafter.

  

There can be no assurance that we will be able to raise capital in the future or that if we raise additional capital, it will be sufficient to execute our business plan. To the extent that we are unable to raise sufficient additional capital, we will be required to substantially modify our business plan and our plans for operations, which could have a material adverse effect on us and our financial condition.

 

Forward Looking Statements

 

This quarterly report includes forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements are based on our management’s beliefs and assumptions and on information currently available to our management. Forward-looking statements include statements concerning:

 

  · Our cash needs and financing plans;
  · Our possible or assumed future results of operations;
  · Our business strategies;
  · Our ability to attract and retain customers;
  · Our ability to sell additional products and services to customers;
  · Our competitive position;
  · Our industry environment;
  · Our potential growth opportunities;
  · Expected technological advances by us or by third parties and our ability to leverage them;
  · The effects of future regulation; and
  · The effects of competition.

 

27 

 

 

All statements in this quarterly report that are not historical facts are forward-looking statements. We may, in some cases, use terms such as “anticipates,” “believes,” “could,” “estimates,” “expects,” “intends,” “may,” “plans,” “potential,” “predicts,” “projects,” “should,” “will,” “would” or similar expressions that convey uncertainty of future events or outcomes to identify forward-looking statements.

 

The outcome of the events described in these forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performances or achievements expressed or implied by the forward-looking statements.

 

All such forward-looking statements are subject to certain risks and uncertainties and should be evaluated in light of important risk factors. These risk factors include, but are not limited to, those that are described in “Risk Factors” under Item 1A and elsewhere in our 2016 annual report on Form 10-K and other filings we make with the Securities and Exchange Commission and the following: business and economic conditions, rapid technological changes accompanied by frequent new product introductions, competitive pressures, dependence on key customers, inability to gauge order flows from customers, fluctuations in quarterly and annual results, the reliance on a limited number of third party suppliers, limitations of our manufacturing capacity and arrangements, the protection of our proprietary technology, the effects of pending or threatened litigation, the dependence on key personnel, changes in critical accounting estimates, potential impairments related to investments, foreign regulations, liquidity issues, and potential material weaknesses in internal control over financial reporting. Further, during weak or uncertain economic periods, customers’ may delay the placement of their orders. These factors often result in a substantial portion of our revenue being derived from orders placed within a quarter and shipped in the final month of the same quarter.

 

Any of these factors could cause our actual results to differ materially from our anticipated results. We caution readers to carefully consider such factors. Many of these factors are beyond our control. In addition, any forward-looking statements represent our estimates only as of the date they are made, and should not be relied upon as representing our estimates as of any subsequent date. While we may elect to update forward-looking statements at some point in the future, except as may be required under applicable securities laws, we specifically disclaim any obligation to do so, even if our estimates change.

   

Item 3. Quantitative and Qualitative Disclosures about Market Risk

 

We invest our excess cash in high-quality short-term corporate debt instruments, which bear lower levels of relative risk. We believe that the effect, if any, of reasonably possible near-term changes in interest rates on our financial position, results of operations, and cash flows should not be material to our cash flows or income. It is possible that interest rate movements would increase our unrealized gain or loss on interest rate securities. We are exposed to changes in foreign currency exchange rates primarily through transaction gains and losses as a result of non U.S. dollar denominated cash flows related to business activities in Japan and Europe. We do not currently hedge our foreign currency exchange rate risk. We estimate that any market risk associated with our international operations is unlikely to have a material adverse effect on our business, financial condition or results of operation.

 

28 

 

 

Item 4. Controls and Procedures  

 

Evaluation of Disclosure Controls and Procedures

 

Management, with the participation of the Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), has performed an evaluation of our disclosure controls and procedures that are defined in Rule 13a-15 of the Exchange Act as of the end of the period covered by this report. This evaluation included consideration of the controls, processes, and procedures that are designed to ensure that information required to be disclosed by us in the reports we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the rules and forms of the SEC and that such information is accumulated and communicated to our management, including our CEO and CFO, as appropriate to allow timely decisions regarding required disclosure. Based on this evaluation, our management, including our CEO and CFO, concluded that, as of June 30, 2017, our disclosure controls and procedures were effective.

 

Changes in Internal Control over Financial Reporting

 

There have not been any changes in internal control over financial reporting (as defined in 13a-15(f) and 15d-15(f) promulgated under the Securities Exchange Act of 1934) that occurred during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, the internal control over financial reporting.

 

29 

 

  

Part II. OTHER INFORMATION

 

Item 1. Legal Proceedings

 

We are not currently involved in any pending legal proceeding or litigation and we are not aware of any such proceedings contemplated by or against us or our property.

 

Item 1A. Risk Factors

 

In addition to the other information set forth in this report you should carefully consider the factors discussed in Part I, Item 1A. “Risk Factors” in our annual report on Form 10-K for the year ended December 31, 2016. There have been no material changes from those risk factors. The risks discussed in our 2016 annual report could materially affect our business, financial condition and future results.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

Sale of Unregistered Securities –

 

  - During the three months ended June 30, 2017, we issued 211 shares of common stock upon the exercise of stock options.

 

  - During the three months ended June 30, 2017, we issued 532,152 shares of common stock upon conversion of convertible notes in the principal amount of $1,043,750 and $153,591 of accrued interest.

 

In connection with the foregoing, we relied upon the exemption from registration provided by Section 4(a)(2) under the Securities Act of 1933, as amended, for transactions not involving a public offering.

 

Purchase of Equity Securities – none

 

Item 3. Defaults Upon Senior Securities

 

None

 

Item 4. Mine Safety Disclosures 

 

Not Applicable

 

Item 5. Other Information

 

None

 

30 

 

 

 

Item 6. Exhibits

 

Exhibit No.   Description
     
31.1   Certification of the Chief Executive Officer of the Registrant pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
     
31.2   Certification of the Chief Financial Officer of the Registrant pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
     
32.1   Certification of the Chief Executive Officer of the Registrant pursuant to 18 U.S.C. Section 1350 adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
     
32.2   Certification of the Chief Financial Officer of the Registrant pursuant to 18 U.S.C. Section 1350 adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
     
101.INS   XBRL Instance Document
     
101.SCH   XBRL Taxonomy Extension Schema Document
     
101.CAL   XBRL Taxonomy Extension Calculation Link base Document 
     
101.DEF   XBRL Taxonomy Extension Definition Link base
     
101.LAB   XBRL Taxonomy Extension Label Link base Document
     
101.PRE   XBRL Taxonomy Extension Presentation Link base Document

 

31 

 

  

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  VUZIX CORPORATION
     
Date: August 9, 2017 By: /s/ Paul J. Travers
    Paul J. Travers
    President, Chief Executive Officer
    (Principal Executive Officer)
     
Date: August 9, 2017 By: /s/ Grant Russell
    Grant Russell
    Executive Vice President and Chief Financial Officer
    (Principal Financial and Accounting Officer)

 

32